The regulation of the Nrf2 pathway by dexamethasone (Dex) has been confirmed by other scholars [14], but whether the underlying mechanism of its effective treatment of COPD is to interfere with pyroptosis by inhibiting NLRP3 remains to be explored. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.